Fate Therapeutics Receives $1,000,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3e04fb64-014e-4b5e-b5c7-17fb520e3ee4&Preview=1
Date
4/20/2011
Company Name
Fate Therapeutics
Mailing Address
3535 General Atomics Court San Diego, CA 92121
Company Description
The company’s revolutionary platform focuses on both regenerative and reprogramming medicine. Fate’s regenerative medicine platform involves developing drugs that awaken adult stem cells in the body to repair damaged cells and tissues. Fate’s reprogramming medicine platform involves developing drugs to reprogram mature adult cells into stem cells which when differentiated can become healthy heart, bone, brain or other tissues.
Website
http://www.fatetherapeutics.com
Transaction Type
Debt
Transaction Amount
$1,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed